Pharmafile Logo
Pharmafocus logo
Advanced Search

UK hit hard as AstraZeneca reveals R&D cuts

March 3, 2010
Research and Development AstraZeneca, job cuts

Nearly 3,500 R&D jobs will be affected at AstraZeneca in the coming months as the pharmaceutical giant exits discovery research …

News
OgilvyAdrianKemsley

Adrian Kemsley joins Ogilvy Healthworld

March 3, 2010
Medical Communications Ogilvy, appointment, medical communications, ogilvy healthworld advertising

Ogilvy Healthworld Advertising has appointed Adrian Kemsley as creative director and overall lead for the agency and unveiled a new …

Appointment

Dr Olaf Stange to head up Bayer Technology in Singapore

March 3, 2010
Manufacturing and Production Bayer Technology Services, appointment, manufacturing and production

Bayer has appointed Dr Olaf Stange to head up its new Southeast Asia regional office for Bayer Technology Services (BTS) …

Appointment

Stability data issue holds up Adventrx cancer drug

March 3, 2010
Manufacturing and Production, Sales and Marketing Adventrx, Cancer, vinorelbine

US drugmaker Adventrx Pharmaceuticals has had the marketing application for its cancer drug ANX-530 (vinorelbine emulsion) rejected by the US …

News
Blog footer

Digital Pharma: AZ outlines its online principles

March 2, 2010
Medical Communications FDA, digital pharma, social media

AstraZeneca says it has an obligation to use social media to help empower patients and prescribers to make informed decisions …

Feature
OSI Pharmaceuticals

Astellas moves in on OSI Pharmaceuticals

March 2, 2010
Sales and Marketing Astellas, Astellas Pharma Europe, OSI

Astellas has launched a hostile takeover bid for OSI Pharmaceuticals, going directly to stockholders with a proposal that values the US …

News

Warner Chilcott sees major jump in revenue

March 2, 2010
P&G, Warner Chilcott

Warner Chilcott saw a big increase in 2009 revenue thanks to its acquisition of Proctor and Gamble’s branded pharmaceuticals business. …

News

Merck shows off expanded pipeline

March 2, 2010
Sales and Marketing Merck, Schering-Plough

Merck has put its new pipeline on display for the first time since its October merger with Schering-Plough was completed. …

News

Shire launches Vpriv to capitalise on Genzyme woes

March 2, 2010
Sales and Marketing Cerezyme, Gaucher's, Shire

Shire has gained US approval to launch Vpriv, its new treatment for Gaucher’s disease, which it hopes will steal market …

News
ResearchPartnershipDavidWhite

David White joins The Research Partnership

March 2, 2010
Sales and Marketing The Research Partnership, appointment, sales and marketing

The Research Partnership has appointed David White director of syndicated services. Based in London, David will oversee the development and …

Appointment

Kinex Pharmaceuticals appoints Rudolf Kwan

March 2, 2010
Research and Development Kinex Pharmaceuticals, appointment, research and development

Dr Rudolf Kwan has joined Buffalo, US-based  Kinex Pharmaceuticals as chief medical officer. He will be responsible for the design …

Appointment

Clinical research news in brief

March 2, 2010
Research and Development Community Research, Evotec, FDA, INC Research, Kendle, Parexel

A round-up of recent developments in the clinical research arena includes proposals from the FDA on reporting falsified trials, Kendle’s …

News

Quotient Bioresearch Presents Comprehensive Drug Development Capabilities via New Company Website

March 1, 2010
Research and Development

Quotient Bioresearch partners its clients with a unique offering of leading-edge technologies and services for all stages of early drug …

News
Press release
Merck KGaA

Merck KGaA invests in bioresearch and bioproduction

March 1, 2010
Manufacturing and Production, Research and Development Biochemistry, Merck KGaA, Merck Serono, Millipore, laboratory services

Merck KGaA has bought US life sciences company Millipore Corporation in a $7.2 billion deal to expand its chemicals business. …

News

Single orphan document will simplify process for industry

March 1, 2010
Research and Development EMA, FDA, Orphan

The FDA and European Medicines Agency are to simplify the regulatory process for orphan medicines by agreeing to accept a …

News
Brazil

Emerging Markets: finding your way in a Brave New World

March 1, 2010
Sales and Marketing Brazil, China, India, Russia, em, emerging markets, sales, sales force effectiveness

Ask almost any pharmaceutical marketer where the future growth lies for the industry, and the answer will be almost certainly …

Feature

Kerrita McClaughlyn joins Hill & Knowlton

March 1, 2010
Medical Communications Hill & Knowlton, appointment, medical communications

Hill & Knowlton International Belgium has appointed Kerrita McClaughlyn as an account manager in its healthcare communications team. In her …

Appointment
ICON headquarters

ICON sees revenues rise in 2009

March 1, 2010
Research and Development CRO, ICON

Contract research organisation ICON saw its revenues increase 3% to $888 million last year and says it is “positive, though …

News

Pfizer’s Kristin Peck gains business development role

March 1, 2010
Sales and Marketing Pfizer, appointment, sales and marketing

Kristin Peck has been appointed senior vice president, worldwide business development, strategy and innovation at Pfizer. She succeeds William Ringo …

Appointment

Alimta recommended as maintenance therapy

March 1, 2010
Sales and Marketing Alimta, Cancer, NSCLC, lilly

 NICE has recommended Alimta as a maintenance treatment for people with locally advanced or metastatic non-small cell lung cancer. Patients …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026